South Korea Clinical Trial Imaging Market Size & Outlook
Related Markets
South Korea clinical trial imaging market highlights
- The South Korea clinical trial imaging market generated a revenue of USD 30.9 million in 2024 and is expected to reach USD 47.8 million by 2030.
- The South Korea market is expected to grow at a CAGR of 7.6% from 2025 to 2030.
- In terms of segment, computed tomography scan was the largest revenue generating modality in 2024.
- Magnetic Resonance Imaging is the most lucrative modality segment registering the fastest growth during the forecast period.
Clinical trial imaging market data book summary
| Market revenue in 2024 | USD 30.9 million |
| Market revenue in 2030 | USD 47.8 million |
| Growth rate | 7.6% (CAGR from 2025 to 2030) |
| Largest segment | Computed tomography scan |
| Fastest growing segment | Magnetic Resonance Imaging |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Computed Tomography Scan, Magnetic Resonance Imaging, X-Ray, Ultrasound, Optical Coherence Tomography (OCT), Other Modalities |
| Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.5% of the global clinical trial imaging market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan clinical trial imaging market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 63.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Imaging Market Scope
Clinical Trial Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Resonance Health | View profile | 1-10 | Claremont, Western Australia, Australia, Oceania | http://resonancehealth.com |
| Intrinsic Imaging | View profile | 51-100 | Bolton, Massachusetts, United States, North America | http://www.intrinsicimaging.com |
| Cardiovascular Imaging Technologies | View profile | - | Kansas City, Missouri, United States, North America | https://www.cvit.com |
| ProScan Imaging | View profile | 251-500 | Cincinnati, Ohio, United States, North America | http://www.proscan.com/ |
| Clario | View profile | 5001-10000 | Philadelphia, Pennsylvania, United States, North America | https://clario.com/ |
| Ixico | View profile | 51-100 | London, England, United Kingdom, Europe | http://www.ixico.com |
| BioTelemetry | View profile | 1001-5000 | Malvern, Pennsylvania, United States, North America | https://www.gobio.com |
| Navitas Organics | View profile | 51-100 | Novato, California, United States, North America | https://navitasorganics.com/ |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
South Korea clinical trial imaging market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Computed tomography scan was the largest segment with a revenue share of 27.83% in 2024. Horizon Databook has segmented the South Korea clinical trial imaging market based on computed tomography scan, magnetic resonance imaging, x-ray, ultrasound, optical coherence tomography (oct), other modalities covering the revenue growth of each sub-segment from 2018 to 2030.
Clinical trial imaging market in South Korea is expected to exhibit gradual growth during the forecast period. South Korea has become one of the top Asian countries for conducting clinical trials owing to the presence of quality clinical research infrastructure.
Moreover, the country has recently implemented various protection and safety requirements for clinical trial participants. Moreover, the government has partnered with large CROs to provide effective clinical trial services in the country.
In September 2019, South Korea launched a five-year plan for advancing clinical trials in the country. One of the major advantages that is being offered under this plan is accelerated clinical trial study with reduced review timelines of around 15 to 20 days.
Reasons to subscribe to South Korea clinical trial imaging market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea clinical trial imaging market databook
-
Our clientele includes a mix of clinical trial imaging market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into South Korea clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea clinical trial imaging market size, by modality, 2018-2030 (US$M)
South Korea Clinical Trial Imaging Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
